 NEEDHAM, Mass., Nov. 16, 2020 GLOBE NEWSWIRE -- Chiasma, Inc. NASDAQ: CHMA, a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases on burdensome and painful injections, today announced that management will be participating in the Jefferies Virtual London Healthcare Conference, which is being held November 17-19. Details of the presentation are as follows: 